Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 562 in Subjects With r/r Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, or Follicular Lymphoma

Clinical trial NCT03571828 · TERMINATED

Trial details

NCT number: NCT03571828
Sponsor: Amgen
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Diffuse Large B-cell Lymphoma(DLBCL)Mantle Cell Lymphoma (MCL)Follicular Lymphoma (FL)

Start date: 2018-10-29
Primary completion: 2022-01-12
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.